Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ:ICLR) is a clinical research organization. The ...

ICON Public Limited Company (NASDAQ:ICLR) is a leading healthcare intelligence and clinical research organization innovating next-gen therapies for better patient outcomes. The company outsources ...

LVS Advisory, a New York City-based full-service investment firm, recently released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Buy to Hold. Analyst Price Forecast Suggests 68.84% Upside As of April 2, 2025, ...

NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to ...

This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic ...

ICON's two largest customers were diversifying their clinical research organization providers away from the Company; (f)as a result of (a)-(e) above, ICON's reported net new business awards and ...

The upcoming 15th Annual Outsourcing in Clinical Trials Europe conference will cover a wide range of topics on clinical ...

In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ ... The reason is simple: our research has shown that we can outperform the market by imitating the top stock ...

The global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027).

Novak Djokovic begins his day with the same drink every single time as he claims it "detoxifys" his body - but doctors have dispelled rumours that it is a cure-all for various ailments ...